Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013, Article ID 301982, 15 pages
http://dx.doi.org/10.1155/2013/301982
Review Article

Oxidative Stress and Nucleic Acid Oxidation in Patients with Chronic Kidney Disease

1Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, No. 325, Section 2, Cheng-Kung Road, Neihu, Taipei 114, Taiwan
2Graduate Institute of Medical Science, National Defense Medical Center, Taipei 114, Taiwan
3Division of Neurology, Department of Medicine, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan 330, Taiwan
4Division of Nephrology, Department of Medicine, Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare, New Taipei City 235, Taiwan
5Graduate Institute of Clinical Medical, Taipei Medical University, Taipei 110, Taiwan
6Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Taipei 114, Taiwan

Received 7 May 2013; Revised 16 July 2013; Accepted 22 July 2013

Academic Editor: Mu-Rong Chao

Copyright © 2013 Chih-Chien Sung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Maisonneuve, L. Agodoa, R. Gellert et al., “Cancer in patients on dialysis for end-stage renal disease: an international collaborative study,” The Lancet, vol. 354, no. 9173, pp. 93–99, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Teschner, C. Garte, H. Rückle-Lanz et al., “Incidence and spectrum of malignant disease among dialysis patients in North Bavaria,” Deutsche Medizinische Wochenschrift, vol. 127, no. 47, pp. 2497–2502, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. N. D. Vaziri, F. Oveisi, and Y. Ding, “Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension,” Kidney International, vol. 53, no. 6, pp. 1748–1754, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Tepel, M. Echelmeyer, N. N. Orie, and W. Zidek, “Increased intracellular reactive oxygen species in patients with end-stage renal failure: effect of hemodialysis,” Kidney International, vol. 58, no. 2, pp. 867–872, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Galle, “Oxidative stress in chronic renal failure,” Nephrology Dialysis Transplantation, vol. 16, no. 11, pp. 2135–2137, 2001. View at Google Scholar · View at Scopus
  6. S. Palleschi, S. de Angelis, L. Diana et al., “Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 9, pp. 1211–1218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Halliwell and J. M. C. Gutteridge, Free Radicals in Biology and Medicine, Oxford University Press, Oxford, UK, 3rd edition, 1999.
  8. P. R. Errakonda, R. Paladugu, A. R. Bitla et al., “Effect of a single hemodialysis session on endothelial dysfunction,” Journal of Nephrology, vol. 24, no. 1, pp. 83–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Dursun, E. Dursun, G. Suleymanlar et al., “Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis,” Nephrology Dialysis Transplantation, vol. 23, no. 5, pp. 1697–1703, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. T. Diplock, J.-L. Charleux, G. Crozier-Willi et al., “Functional food science and defence against reactive oxidative,” British Journal of Nutrition, vol. 80, supplement 1, pp. S77–S112, 1998. View at Google Scholar · View at Scopus
  11. B. N. Ames, “Endogenous oxidative DNA damage, aging and cancer,” Free Radical Research Communications, vol. 7, no. 3–6, pp. 121–128, 1989. View at Google Scholar · View at Scopus
  12. W. A. Schulz, M. S. W. Obendorf, and H. Sies, “Localization of strand breaks in plasmid DNA treated with reactive oxygen species,” Methods in Enzymology, vol. 234, pp. 45–51, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. K. B. Beckman and B. N. Ames, “Oxidative decay of DNA,” Journal of Biological Chemistry, vol. 272, no. 32, pp. 19633–19636, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Descamps-Latscha, T. Drüeke, and V. Witko-Sarsat, “Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy,” Seminars in Dialysis, vol. 14, no. 3, pp. 193–199, 2001. View at Google Scholar · View at Scopus
  15. K. Bedard and K.-H. Krause, “The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology,” Physiological Reviews, vol. 87, no. 1, pp. 245–313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. S. Beckman, T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman, “Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 4, pp. 1620–1624, 1990. View at Google Scholar · View at Scopus
  17. K. J. Davies, “Protein damage and degradation by oxygen radicals. I. general aspects,” Journal of Biological Chemistry, vol. 262, no. 20, pp. 9895–9901, 1987. View at Google Scholar · View at Scopus
  18. S. P. Wolff, A. Garner, and R. T. Dean, “Free radicals, lipids and protein degradation,” Trends in Biochemical Sciences, vol. 11, no. 1, pp. 27–31, 1986. View at Google Scholar · View at Scopus
  19. J. A. Imlay and S. Linn, “DNA damage and oxygen radical toxicity,” Science, vol. 240, no. 4857, pp. 1302–1309, 1988. View at Google Scholar · View at Scopus
  20. F. Locatelli, B. Canaud, K.-U. Eckardt, P. Stenvinkel, C. Wanner, and C. Zoccali, “Oxidative stress in end-stage renal disease: an emerging treat to patient outcome,” Nephrology Dialysis Transplantation, vol. 18, no. 7, pp. 1272–1280, 2003. View at Google Scholar · View at Scopus
  21. Z. Wang, S. J. Nicholls, E. R. Rodriguez et al., “Protein carbamylation links inflammation, smoking, uremia and atherogenesis,” Nature Medicine, vol. 13, no. 10, pp. 1176–1184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Kalantar-Zadeh, M.-L. Brennan, and S. L. Hazen, “Serum myeloperoxidase and mortality in maintenance hemodialysis patients,” The American Journal of Kidney Diseases, vol. 48, no. 1, pp. 59–68, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. P. Cristol, B. Canaud, H. Rabesandratana, I. Gaillard, A. Serre, and C. Mion, “Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis,” Nephrology Dialysis Transplantation, vol. 9, no. 4, pp. 389–394, 1994. View at Google Scholar · View at Scopus
  24. M.-F. Chen, C.-L. Chang, and S.-Y. Liou, “Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis,” Blood Purification, vol. 16, no. 5, pp. 290–300, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Ghezzi, V. Bonetto, and M. Fratelli, “Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation,” Antioxidants and Redox Signaling, vol. 7, no. 7-8, pp. 964–972, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Himmelfarb, “Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy,” Seminars in Dialysis, vol. 22, no. 6, pp. 636–643, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Himmelfarb, P. Stenvinkel, T. A. Ikizler, and R. M. Hakim, “Perspectives in renal medicine: the elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia,” Kidney International, vol. 62, no. 5, pp. 1524–1538, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Scholze, C. Rinder, J. Beige, R. Riezler, W. Zidek, and M. Tepel, “Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure,” Circulation, vol. 109, no. 3, pp. 369–374, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. M. C. Gongora, H. E. Lob, U. Landmesser et al., “Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome,” The American Journal of Pathology, vol. 173, no. 4, pp. 915–926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Kobayashi, H. Sugiyama, D.-H. Wang et al., “Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice,” Kidney International, vol. 68, no. 3, pp. 1018–1031, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Ursini, M. Maiorino, and C. Gregolin, “The selenoenzyme phospholipid hydroperoxide glutathione peroxidase,” Biochimica et Biophysica Acta, vol. 839, no. 1, pp. 62–70, 1985. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Avissar, D. B. Ornt, Y. Yagil et al., “Human kidney proximal tubules are the main source of plasma glutathione peroxidase,” The American Journal of Physiology, vol. 266, no. 2, pp. C367–C375, 1994. View at Google Scholar · View at Scopus
  33. Z. A. Wood, E. Schröder, J. R. Harris, and L. B. Poole, “Structure, mechanism and regulation of peroxiredoxins,” Trends in Biochemical Sciences, vol. 28, no. 1, pp. 32–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Canaud, J.-P. Cristol, M. Morena, H. Leray-Moragues, J.-Y. Bosc, and F. Vaussenat, “Imbalance of oxidants and antioxidants in haemodialysis patients,” Blood Purification, vol. 17, no. 2-3, pp. 99–106, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Ceballos-Picot, V. Witko-Sarsat, M. Merad-Boudia et al., “Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure,” Free Radical Biology and Medicine, vol. 21, no. 6, pp. 845–853, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Bonomini and A. Albertazzi, “Selenium in uremia,” Artificial Organs, vol. 19, no. 5, pp. 443–448, 1995. View at Google Scholar · View at Scopus
  37. D.-C. Tarng, T.-J. Tsai, W.-T. Chen, T.-Y. Liu, and Y.-H. Wei, “Effect of human OGG1 1245C→G gene polymorphism on 8-hydroxy-2′-deoxyguanosine levels of leukocyte DNA among patients undergoing chronic hemodialysis,” Journal of the American Society of Nephrology, vol. 12, no. 11, pp. 2338–2347, 2001. View at Google Scholar · View at Scopus
  38. T. Kohno, K. Shinmura, M. Tosaka et al., “Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA,” Oncogene, vol. 16, no. 25, pp. 3219–3225, 1998. View at Google Scholar · View at Scopus
  39. S. Trabulus, G. S. Guven, M. R. Altiparmak et al., “DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease,” Molecular Biology Reports, vol. 39, pp. 6995–7001, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. Cai, H. Chen, J. Tao et al., “Association of base excision repair gene polymorphisms with ESRD risk in a Chinese population,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 928421, 2012. View at Publisher · View at Google Scholar
  41. A. Crawford, R. G. Fassett, J. S. Coombes et al., “Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease,” Nephrology Dialysis Transplantation, vol. 26, no. 9, pp. 2806–2813, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Himmelfarb, “Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?” Seminars in Dialysis, vol. 17, no. 6, pp. 449–454, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Crawford, R. G. Fassett, D. P. Geraghty et al., “Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease,” Gene, vol. 501, pp. 89–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. Y.-S. Lin, S.-C. Hung, Y.-H. Wei, and D.-C. Tarng, “GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients,” Journal of the American Society of Nephrology, vol. 20, no. 2, pp. 405–415, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Boaz, S. Smetana, T. Weinstein et al., “Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial,” The Lancet, vol. 356, no. 9237, pp. 1213–1218, 2000. View at Google Scholar · View at Scopus
  46. J. F. E. Mann, E. M. Lonn, Q. Yi et al., “Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE Study,” Kidney International, vol. 65, no. 4, pp. 1375–1380, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Tepel, M. van der Giet, M. Statz, J. Jankowski, and W. Zidek, “The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial,” Circulation, vol. 107, no. 7, pp. 992–995, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. D.-C. Tarng, T.-Y. Liu, and T.-P. Huang, “Protective effect of vitamin C on 8-hydroxy-2′-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients,” Kidney International, vol. 66, no. 2, pp. 820–831, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Kayabasi, Z. Yilmaz, D. Sit, A. K. Kadiroglu, and E. Yilmaz, “The effects of Losartan on oxidative stress and inflammation in non-diabetic patients undergoing chronic hemodialysis,” European Review For Medical and Pharmacological Sciences, vol. 17, pp. 235–242, 2013. View at Google Scholar
  50. V. D. A. Delfino, A. C. de Andrade Vianna, A. J. Mocelin, D. S. Barbosa, R. A. Mise, and T. Matsuo, “Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients,” Nutrition, vol. 23, no. 3, pp. 242–247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. P. E. Pergola, P. Raskin, R. D. Toto et al., “Bardoxolone methyl and kidney function in CKD with type 2 diabetes,” The New England Journal of Medicine, vol. 365, no. 4, pp. 327–336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. B. P. Oberg, E. McMenamin, F. L. Lucas et al., “Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease,” Kidney International, vol. 65, no. 3, pp. 1009–1016, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Taki, Y. Tsuruta, and T. Niwa, “Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients,” The American Journal of Nephrology, vol. 27, no. 1, pp. 30–35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. Z. Tumur, H. Shimizu, A. Enomoto, H. Miyazaki, and T. Niwa, “Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-κB activation,” The American Journal of Nephrology, vol. 31, no. 5, pp. 435–441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. N. Friedman, A. G. Bostom, J. Selhub, A. S. Levey, and I. H. Rosenberg, “The kidney and homocysteine metabolism,” Journal of the American Society of Nephrology, vol. 12, no. 10, pp. 2181–2189, 2001. View at Google Scholar · View at Scopus
  56. Z. A. Massy, I. Ceballos, B. Chadefaux-Vekemens et al., “Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients,” Kidney International, vol. 59, supplement, no. 78, pp. S243–S245, 2001. View at Google Scholar · View at Scopus
  57. D. Ingrosso, A. Cimmino, A. F. Perna et al., “Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia,” The Lancet, vol. 361, no. 9370, pp. 1693–1699, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. J. E. Dodget, M. Okano, F. Dick et al., “Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization,” Journal of Biological Chemistry, vol. 280, no. 18, pp. 17986–17991, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Gugliucci, K. Kotani, and S. Kimura, “Paraoxonase 1 in chronic kidney failure,” Journal of Lipids, vol. 2012, Article ID 726048, 10 pages, 2012. View at Publisher · View at Google Scholar
  60. P. S. Tucker, V. J. Dalbo, T. Han, and M. I. Kingsley, “Clinical and research markers of oxidative stress in chronic kidney disease,” Biomarkers, vol. 18, pp. 103–115, 2013. View at Google Scholar
  61. R. A. Ward and K. R. McLeish, “Oxidant stress in hemodialysis patients: what are the determining factors?” Artificial Organs, vol. 27, no. 3, pp. 230–236, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. C.-C. Wu, J.-S. Chen, W.-M. Wu et al., “Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes,” Nephrology Dialysis Transplantation, vol. 20, pp. 1134–1139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. A. T. Nguyen, C. Lethias, and J. Zingraff, “Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood,” Kidney International, vol. 28, no. 2, pp. 158–167, 1985. View at Google Scholar · View at Scopus
  64. R. A. Ward, R. Ouseph, and K. R. McLeish, “Effects of high-flux hemodialysis on oxidant stress,” Kidney International, vol. 63, no. 1, pp. 353–359, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Maggi, R. Bellazzi, F. Falaschi et al., “Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis?” Kidney International, vol. 45, no. 3, pp. 876–883, 1994. View at Google Scholar · View at Scopus
  66. L. F. Ramos, A. Shintani, T. A. Ikizler, and J. Himmelfarb, “Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD,” Journal of the American Society of Nephrology, vol. 19, no. 3, pp. 593–599, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. J.-L. Chen, Y.-J. Huang, C.-H. Pan, C.-W. Hu, and M.-R. Chao, “Determination of urinary malondialdehyde by isotope dilution LC-MS/MS with automated solid-phase extraction: a cautionary note on derivatization optimization,” Free Radical Biology and Medicine, vol. 51, no. 9, pp. 1823–1829, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. J. L. Paul, N.-D. Sall, T. Soni et al., “Lipid peroxidation abnormalities in hemodialyzed patients,” Nephron, vol. 64, no. 1, pp. 106–109, 1993. View at Google Scholar · View at Scopus
  69. H. Esterbauer, R. J. Schaur, and H. Zollner, “Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes,” Free Radical Biology and Medicine, vol. 11, no. 1, pp. 81–128, 1991. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Miyata, K. Kurokawa, and C. van Ypersele de Strihou, “Relevance of oxidative and carbonyl stress to long-term uremic complications,” Kidney International, vol. 58, supplement, no. 76, pp. S120–S125, 2000. View at Google Scholar · View at Scopus
  71. S. Aslam, T. Santha, A. Leone, and C. Wilcox, “Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis,” Kidney International, vol. 70, no. 12, pp. 2109–2115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. J. D. Morrow, J. A. Awad, H. J. Boss, I. A. Blair, and L. J. Roberts II, “Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 22, pp. 10721–10725, 1992. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Morena, S. Delbosc, A.-M. Dupuy, B. Canaud, and J.-P. Cristol, “Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation,” Hemodialysis International, vol. 9, no. 1, pp. 37–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. R. Ramos and A. Martínez-Castelao, “Lipoperoxidation and hemodialysis,” Metabolism, vol. 57, no. 10, pp. 1369–1374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Caimi, C. Carollo, M. Montana, R. Iatrino, B. Bondì, and R. Lo Presti, “Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects,” Blood Purification, vol. 27, no. 2, pp. 194–198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. V. Witko-Sarsat, M. Friedlander, C. Capeillère-Blandin et al., “Advanced oxidation protein products as a novel marker of oxidative stress in uremia,” Kidney International, vol. 49, no. 5, pp. 1304–1313, 1996. View at Google Scholar · View at Scopus
  77. P. S. Modlinger, C. S. Wilcox, and S. Aslam, “Nitric oxide, oxidative stress, and progression of chronic renal failure,” Seminars in Nephrology, vol. 24, no. 4, pp. 354–365, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Erdoğan, Y. Unlüçerçi, A. Türkmen, A. Kuru, O. Cetin, and S. Bekpinar, “The evaluation of oxidative stress in patients with chronic renal failure,” Clinica Chimica Acta, vol. 322, pp. 157–161, 2002. View at Google Scholar
  79. M. Pischetsrieder, W. Seidel, G. Münch, and R. Schinzel, “N2-(1-carboxyethyl)deoxyguanosine, a nonenzymatic glycation adduct of DNA, induces single-strand breaks and increases mutation frequencies,” Biochemical and Biophysical Research Communications, vol. 264, no. 2, pp. 544–549, 1999. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Valko, M. Izakovic, M. Mazur, C. J. Rhodes, and J. Telser, “Role of oxygen radicals in DNA damage and cancer incidence,” Molecular and Cellular Biochemistry, vol. 266, no. 1-2, pp. 37–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. H. Kasai, “Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis,” Mutation Research, vol. 387, no. 3, pp. 147–163, 1997. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, “Free radicals, metals and antioxidants in oxidative stress-induced cancer,” Chemico-Biological Interactions, vol. 160, no. 1, pp. 1–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Collins, “Comparison of different methods of measuring 8-oxoguanine as a marker of oxidative DNA damage,” Free Radical Research, vol. 32, no. 4, pp. 333–341, 2000. View at Google Scholar · View at Scopus
  84. A. Valavanidis, T. Vlachogianni, and C. Fiotakis, “8-hydroxy-2′-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis,” Journal of Environmental Science and Health, vol. 27, no. 2, pp. 120–139, 2009. View at Google Scholar · View at Scopus
  85. H. Orhan, B. van Holland, B. Krab et al., “Evaluation of a multi-parameter biomarker set for oxidative damage in man: increased urinary excretion of lipid, protein and DNA oxidation products after one hour of exercise,” Free Radical Research, vol. 38, no. 12, pp. 1269–1279, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. C. M. Gedik, S. P. Boyle, S. G. Wood, N. J. Vaughan, and A. R. Collins, “Oxidative stress in humans: validation of biomarkers of DNA damage,” Carcinogenesis, vol. 23, no. 9, pp. 1441–1446, 2002. View at Google Scholar · View at Scopus
  87. H. Kasai, “Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis,” Mutation Research, vol. 387, no. 3, pp. 147–163, 1997. View at Publisher · View at Google Scholar · View at Scopus
  88. D.-C. Tarng, T.-P. Huang, Y.-H. Wei et al., “8-Hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients,” The American Journal of Kidney Diseases, vol. 36, no. 5, pp. 934–944, 2000. View at Google Scholar · View at Scopus
  89. D.-C. Tarng, T. W. Chen, T.-P. Huang, C.-L. Chen, T.-Y. Liu, and Y.-H. Wei, “Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients,” Journal of the American Society of Nephrology, vol. 13, no. 5, pp. 1321–1330, 2002. View at Publisher · View at Google Scholar · View at Scopus
  90. C.-W. Hu, M.-R. Chao, and C.-H. Sie, “Urinary analysis of 8-oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine by isotope-dilution LC-MS/MS with automated solid-phase extraction: study of 8-oxo-7,8-dihydroguanine stability,” Free Radical Biology and Medicine, vol. 48, no. 1, pp. 89–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. M. K. Shigenaga, C. J. Gimeno, and B. N. Ames, “Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 24, pp. 9697–9701, 1989. View at Publisher · View at Google Scholar · View at Scopus
  92. M. S. Cooke, R. Olinski, and S. Loft, “Measurement and meaning of oxidatively modified DNA lesions in urine,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 1, pp. 3–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. C.-W. Hu, Y.-J. Huang, Y.-J. Li, and M.-R. Chao, “Correlation between concentrations of 8-oxo-7,8-dihydro-2′-deoxyguanosine in urine, plasma and saliva measured by on-line solid-phase extraction LC-MS/MS,” Clinica Chimica Acta, vol. 411, no. 17-18, pp. 1218–1222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. D. Schiffmann and U. de Boni, “Dislocation of chromatin elements in prophase induced by diethylstilbestrol: a novel mechanism by which micronuclei can arise,” Mutation Research, vol. 246, no. 1, pp. 113–122, 1991. View at Google Scholar · View at Scopus
  95. H. Stopper and S. O. Müller, “Micronuclei as a biological endpoint for genotoxicity: a minireview,” Toxicology In Vitro, vol. 11, no. 5, pp. 661–667, 1997. View at Publisher · View at Google Scholar · View at Scopus
  96. K. Cengiz, A. M. W. Block, D. K. Hossfeld, R. Anthone, S. Anthone, and A. A. Sandberg, “Sister chromatid exchange and chromosome abnormalities in uremic patients,” Cancer Genetics and Cytogenetics, vol. 36, no. 1, pp. 55–67, 1988. View at Google Scholar · View at Scopus
  97. N. P. Singh, M. T. McCoy, R. R. Tice, and E. L. Schneider, “A simple technique for quantitation of low levels of DNA damage in individual cells,” Experimental Cell Research, vol. 175, no. 1, pp. 184–191, 1988. View at Google Scholar · View at Scopus
  98. F. Kassie, W. Parzefall, and S. Knasmüller, “Single cell gel electrophoresis assay: a new technique for human biomonitoring studies,” Mutation Research, vol. 463, no. 1, pp. 13–31, 2000. View at Publisher · View at Google Scholar · View at Scopus
  99. H. Stopper, N. Schupp, A. Klassen, K. Sebekova, and A. Heidland, “Genomic damage in chronic renal failure: potential therapeutic interventions,” Journal of Renal Nutrition, vol. 15, no. 1, pp. 81–86, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. Y.-H. Wei, “Mitochondrial DNA alterations as ageing-associated molecular events,” Mutation Research, vol. 275, no. 3–6, pp. 145–155, 1992. View at Publisher · View at Google Scholar · View at Scopus
  101. C.-S. Liu, L.-Y. Ko, P.-S. Lim, S.-H. Kao, and Y.-H. Wei, “Biomarkers of DNA damage in patients with end-stage renal disease: mitochondrial DNA mutation in hair follicles,” Nephrology Dialysis Transplantation, vol. 16, no. 3, pp. 561–565, 2001. View at Google Scholar · View at Scopus
  102. E. Stoyanova, S. B. Sandoval, L. A. Zúñiga et al., “Oxidative DNA damage in chronic renal failure patients,” Nephrology Dialysis Transplantation, vol. 25, no. 3, pp. 879–885, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Granata, G. Zaza, S. Simone et al., “Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease,” BMC Genomics, vol. 10, article 388, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. H. Stopper, F. Boullay, A. Heidland, J. Vienken, and U. Bahner, “Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients,” The American Journal of Kidney Diseases, vol. 38, pp. 296–301, 2001. View at Google Scholar
  105. T. Malachi, D. Zevin, U. Gafter, A. Chagnac, H. Slor, and J. Levi, “DNA repair and recovery of RNA synthesis in uremic patients,” Kidney International, vol. 44, no. 2, pp. 385–389, 1993. View at Google Scholar · View at Scopus
  106. R. Pinkus, L. M. Weiner, and V. Daniel, “Role of oxidants and antioxidants in the induction of AP-1, NF-κB, and glutathione S-transferase gene expression,” Journal of Biological Chemistry, vol. 271, no. 23, pp. 13422–13429, 1996. View at Publisher · View at Google Scholar · View at Scopus
  107. N. Anilkumar, R. Weber, M. Zhang, A. Brewer, and A. M. Shah, “Nox4 and Nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1347–1354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. P. K. Vayalil, K. E. Iles, J. Choi, A.-K. Yi, E. M. Postlethwait, and R.-M. Liu, “Glutathione suppresses TGF-β-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter,” The American Journal of Physiology, vol. 293, no. 5, pp. L1281–L1292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. P. K. Vayalil, M. Olman, J. E. Murphy-Ullrich, E. M. Postlethwait, and R.-M. Liu, “Glutathione restores collagen degradation in TGF-β-treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogen,” The American Journal of Physiology, vol. 289, no. 6, pp. L937–L945, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. C.-C. Wu, J.-S. Chen, S.-H. Lin et al., “Aberrant activation of the TNF-α system and production of fas and scavenger receptors on monocytes in patients with end-stage renal disease,” Artificial Organs, vol. 29, no. 9, pp. 701–707, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. F. Galli, L. Ghibelli, U. Buoncristiani et al., “Mononuclear leukocyte apoptosis in haemodialysis patients: the role of cell thiols and vitamin E,” Nephrology Dialysis Transplantation, vol. 18, no. 8, pp. 1592–1600, 2003. View at Publisher · View at Google Scholar · View at Scopus
  112. C.-C. Wu, T.-N. Liao, K.-C. Lu et al., “Apoptotic markers on lymphocytes and monocytes are unchanged during single hemodialysis sessions using either regenerated cellulose or polysulfone membranes,” Clinical Nephrology, vol. 64, no. 3, pp. 198–204, 2005. View at Google Scholar · View at Scopus
  113. G. M. London and T. B. Drueke, “Atherosclerosis and arteriosclerosis in chronic renal failure,” Kidney International, vol. 51, no. 6, pp. 1678–1695, 1997. View at Google Scholar · View at Scopus
  114. M. Aviram, M. Rosenblat, A. Etzioni, and R. Levy, “Activation of NADPH oxidase is required for macrophage-mediated oxidation of low-density lipoprotein,” Metabolism, vol. 45, no. 9, pp. 1069–1079, 1996. View at Publisher · View at Google Scholar · View at Scopus
  115. Y. Xia, A.-L. Tsai, V. Berka, and J. L. Zweier, “Superoxide generation from endothelial nitric-oxide synthase: a Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process,” Journal of Biological Chemistry, vol. 273, no. 40, pp. 25804–25808, 1998. View at Publisher · View at Google Scholar · View at Scopus
  116. J. P. Cooke and V. J. Dzau, “Nitric oxide synthase: role in the genesis of vascular disease,” Annual Review of Medicine, vol. 48, pp. 489–509, 1997. View at Publisher · View at Google Scholar · View at Scopus
  117. T. Miyata, O. Oda, R. Inagi et al., “β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis,” Journal of Clinical Investigation, vol. 92, no. 3, pp. 1243–1252, 1993. View at Google Scholar · View at Scopus
  118. C. Capeillere-Blandin, T. Delaveau, and B. Descamps-Latscha, “Structural modifications of human β2 microglobulin treated with oxygen-derived radicals,” Biochemical Journal, vol. 277, no. 1, pp. 175–182, 1991. View at Google Scholar · View at Scopus
  119. K. Šebeková, Z. Wagner, N. Schupp, and P. Boor, “Genomic damage and malignancy in end-stage renal failure: do advanced glycation end products contribute?” Kidney and Blood Pressure Research, vol. 30, no. 1, pp. 56–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Loft and H. E. Poulsen, “Cancer risk and oxidative DNA damage in man,” Journal of Molecular Medicine, vol. 74, pp. 297–312, 1996. View at Google Scholar · View at Scopus
  121. H. Stopper, N. Schupp, U. Bahner, K. Sebekova, A. Klassen, and A. Heidland, “Genomic damage in end-stage renal failure: potential involvement of advanced glycation end products and carbonyl stress,” Seminars in Nephrology, vol. 24, no. 5, pp. 474–478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  122. J. Himmelfarb and R. M. Hakim, “Oxidative stress in uremia,” Current Opinion in Nephrology and Hypertension, vol. 12, pp. 593–598, 2003. View at Google Scholar
  123. S. Devaraj and I. Jialal, “The effects of alpha-tocopherol on critical cells in atherogenesis,” Current Opinion in Lipidology, vol. 9, no. 1, pp. 11–15, 1998. View at Publisher · View at Google Scholar · View at Scopus
  124. M. N. Diaz, B. Frei, J. A. Vita, and J. F. Keaney Jr., “Antioxidants and atherosclerotic heart disease,” The New England Journal of Medicine, vol. 337, no. 6, pp. 408–416, 1997. View at Publisher · View at Google Scholar · View at Scopus
  125. J. Brunet, M.-J. Boily, S. Cordeau, and C. Des Rosiers, “Effects of N-acetylcysteine in the rat heart reperfused after low-flow ischemia: evidence for a direct scavenging of hydroxyl radicals and a nitric oxide-dependent increase in coronary flow,” Free Radical Biology and Medicine, vol. 19, no. 5, pp. 627–638, 1995. View at Publisher · View at Google Scholar · View at Scopus
  126. J. DiMari, J. Megyesi, N. Udvarhelyi, P. Price, R. Davis, and R. Safirstein, “N-acetyl cysteine ameliorates ischemic renal failure,” The American Journal of Physiology, vol. 272, no. 3, pp. F292–F298, 1997. View at Google Scholar · View at Scopus
  127. N. P. Andrews, A. Prasad, and A. A. Quyyumi, “N-acetylcysteine improves coronary and peripheral vascular function,” Journal of the American College of Cardiology, vol. 37, no. 1, pp. 117–123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  128. S.-P. Hsu, C.-K. Chiang, S.-Y. Yang, and C.-T. Chien, “N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients,” Nephron, vol. 116, no. 3, pp. c207–c216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. C. Libetta, V. Sepe, P. Esposito, F. Galli, and A. Dal Canton, “Oxidative stress and inflammation: implications in uremia and hemodialysis,” Clinical Biochemistry, vol. 44, no. 14-15, pp. 1189–1198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  130. G. Nickenig and D. G. Harrison, “The AT1-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis,” Circulation, vol. 105, no. 3, pp. 393–396, 2002. View at Publisher · View at Google Scholar · View at Scopus
  131. M. E. Pueyo, W. Gonzalez, A. Nicoletti, F. Savoie, J.-F. Arnal, and J.-B. Michel, “Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 3, pp. 645–651, 2000. View at Google Scholar · View at Scopus
  132. A. Imaeda, T. Tanigawa, T. Aoki, Y. Kondo, N. Nakamura, and T. Yoshikawa, “Antioxidative effects of fluvastatin and its metabolites against oxidative DNA damage in mammalian cultured cells,” Free Radical Research, vol. 35, no. 6, pp. 789–801, 2001. View at Google Scholar · View at Scopus
  133. M.-P. Wautier, O. Chappey, S. Corda, D. M. Stern, A. M. Schmidt, and J.-L. Wautier, “Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE,” The American Journal of Physiology, vol. 280, no. 5, pp. E685–E694, 2001. View at Google Scholar · View at Scopus
  134. A. Bierhaus, M. A. Hofmann, R. Ziegler, and P. P. Nawroth, “AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept,” Cardiovascular Research, vol. 37, no. 3, pp. 586–600, 1998. View at Publisher · View at Google Scholar · View at Scopus
  135. Z. Krivosíková, M. Dusinská, V. Spustová et al., “DNA damage of lymphocytes in experimental chronic renal failure: beneficial effects of losartan,” Kidney International, vol. 78, supplement, pp. S212–S215, 2001. View at Google Scholar
  136. J. B. Moberly, J. Logan, P. R. Borum et al., “Elevation of whole-blood glutathione in peritoneal dialysis patients by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug (procysteine),” Journal of the American Society of Nephrology, vol. 9, no. 6, pp. 1093–1099, 1998. View at Google Scholar · View at Scopus
  137. H. Stopper, A.-T. Treutlein, U. Bahner et al., “Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation,” Nephrology Dialysis Transplantation, vol. 23, no. 10, pp. 3272–3279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  138. J. Heinz, S. Kropf, C. Luley, and J. Dierkes, “Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis,” The American Journal of Kidney Diseases, vol. 54, no. 3, pp. 478–489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  139. X. Wang and M. Fenech, “A comparison of folic acid and 5-methyltetrahydrofolate for prevention of DNA damage and cell death in human lymphocytes in vitro,” Mutagenesis, vol. 18, no. 1, pp. 81–86, 2003. View at Publisher · View at Google Scholar · View at Scopus
  140. M. Fenech, P. Baghurst, W. Luderer et al., “Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, β-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability: results from a dietary intake and micronucleus index survey in South Australia,” Carcinogenesis, vol. 26, no. 5, pp. 991–999, 2005. View at Publisher · View at Google Scholar · View at Scopus
  141. J. T. MacGregor, C. M. Wehr, R. A. Hiatt et al., “‘Spontaneous’ genetic damage in man: evaluation of interindividual variability, relationship among markers of damage, and influence of nutritional status,” Mutation Research, vol. 377, no. 1, pp. 125–135, 1997. View at Publisher · View at Google Scholar · View at Scopus
  142. N. Titenko-Holland, R. A. Jacob, N. Shang, A. Balaraman, and M. T. Smith, “Micronuclei in lymphocytes and exfoliated buccal cells of postmenopausal women with dietary changes in folate,” Mutation Research, vol. 417, no. 2-3, pp. 101–114, 1998. View at Publisher · View at Google Scholar · View at Scopus
  143. S. Ruiz, P. E. Pergola, R. A. Zager, and N. D. Vaziri, “Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease,” Kidney International, vol. 83, pp. 1029–1041, 2013. View at Google Scholar
  144. A. T. Dinkova-Kostova, K. T. Liby, K. K. Stephenson et al., “Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 12, pp. 4584–4589, 2005. View at Publisher · View at Google Scholar · View at Scopus
  145. M. S. Yates, M. Tauchi, F. Katsuoka et al., “Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes,” Molecular Cancer Therapeutics, vol. 6, no. 1, pp. 154–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  146. M. B. Sporn, K. T. Liby, M. M. Yore, L. Fu, J. M. Lopchuk, and G. W. Gribble, “New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress,” Journal of Natural Products, vol. 74, no. 3, pp. 537–545, 2011. View at Publisher · View at Google Scholar · View at Scopus
  147. A.-L. Levonen, A. Landar, A. Ramachandran et al., “Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products,” Biochemical Journal, vol. 378, no. 2, pp. 373–382, 2004. View at Publisher · View at Google Scholar · View at Scopus
  148. R. Ahmad, D. Raina, C. Meyer, S. Kharbanda, and D. Kufe, “Triterpenoid CDDO-Me blocks the NF-κB pathway by direct inhibition of IKKβ on Cys-179,” Journal of Biological Chemistry, vol. 281, no. 47, pp. 35764–35769, 2006. View at Publisher · View at Google Scholar · View at Scopus
  149. A. Floridi, F. Antolini, F. Galli, R. M. Fagugli, E. Floridi, and U. Buoncristiani, “Daily haemodialysis improves indices of protein glycation,” Nephrology Dialysis Transplantation, vol. 17, no. 5, pp. 871–878, 2002. View at Google Scholar · View at Scopus